HANNEKE SCHUITEMAKER, PH.D.
Vice President, Head, Viral Vaccine Discovery & Translational Medicine
DAS Leader, Viral Vaccines
Hanneke Schuitemaker, Ph.D., is the Head of Viral Vaccine Discovery and Translational Medicine and Disease Area Stronghold Leader for Viral Vaccines at Janssen Vaccines & Prevention B.V. In this role, she oversees Janssen’s viral vaccine programs including investigational vaccine candidates for HIV, respiratory syncytial virus (RSV), Ebola, Zika, COVID-2019 and HPV. In addition, she is a Professor of Virology at the Amsterdam University Medical Center, holding this function since 2004.
Previously, Hanneke worked for more than 20 years on HIV-1 pathogenesis, first at Sanquin (1989-2007), the blood supply foundation in the Netherlands, where she was the chair of the department of Clinical Viro-Immunology (1998-2007), and then at the Amsterdam University Medical Center (2008-2010), where she was the chair of the Department of Experimental Immunology and a member of the Research Council. From mid-2003 to mid-2004, she worked as a visiting scientist at The Scripps Research Institute in La Jolla, California.
Hanneke is a medical biologist by training, receiving her Ph.D. in Medicine in 1992 from the University of Amsterdam She has successfully trained more than 30 Ph.D. students and co-authored close to 300 peer-reviewed scientific articles.
Read more:
- Vaccines: The Heroes of Public Health
- Twenty Years of Progress in Search for an HIV Vaccine
- The Quest for a Global Preventive HIV Vaccine Reaches an Exciting Milestone With the Mosaico Study